I-MAB BIOPHARMA

Serial Number 88519029
Registration 6852814
700

Registration Progress

Application Filed
Jul 17, 2019
Under Examination
Feb 1, 2022
Approved for Publication
Dec 7, 2021
Published for Opposition
Dec 7, 2021
Registered
Sep 20, 2022

Trademark Image

I-MAB BIOPHARMA

Basic Information

Serial Number
88519029
Registration Number
6852814
Filing Date
July 17, 2019
Registration Date
September 20, 2022
Published for Opposition
December 7, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 20, 2022
Registration
Registered
Classes
005 042

Rights Holder

I-MAB BIOPHARMA US LIMITED

03
Address
2440 RESEARCH BLVD, SUITE 400
ROCKVILLE, MD 20850

Ownership History

I-MAB

Original Applicant
03
George Town KY

I-MAB

Owner at Publication
03
George Town KY

I-MAB

Original Registrant
03
George Town KY

I-MAB BIOPHARMA CO., LTD

New Owner After Registration #1
03
SHANGHAI CN

I-MAB BIOPHARMA US LIMITED

New Owner After Registration #2
03
ROCKVILLE, MD

Legal Representation

Attorney
Jacqueline Lesser

USPTO Deadlines

Next Deadline
995 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220920)
Due Date
September 20, 2028
Grace Period Ends
March 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

49 events
Date Code Type Description Documents
Dec 1, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 1, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 1, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 16, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 16, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 25, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 17, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 20, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 20, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 16, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 15, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 12, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 27, 2022 IUAF S USE AMENDMENT FILED Loading...
Aug 12, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 27, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 1, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 7, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 29, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 28, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 28, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 1, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 1, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 1, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 28, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 26, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 26, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Apr 13, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Oct 13, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 9, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 9, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 9, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 11, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 10, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 10, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 24, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 24, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 12, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 10, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 26, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 25, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 20, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders
First Use Anywhere: Dec 21, 2020
First Use in Commerce: Dec 21, 2020
Class 042
Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
First Use Anywhere: Apr 13, 2020
First Use in Commerce: Apr 28, 2020

Additional Information

Design Mark
The mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B." Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters, and below "BIOPHARMA" are four Chinese characters written in green. The color white appearing in the mark represents transparent space and is not a part of the mark.
Color Claim
The color(s) blue, dark blue, green, and light green is/are claimed as a feature of the mark.
Translation
The English translation of non-Latin characters in the mark is "HEAVEN ORGANISM".
Other
The non-Latin characters in the mark transliterate to "TIAN JING SHENG WU" and this means "HEAVEN ORGANISM" in English.

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"